- Trials with a EudraCT protocol (28)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28 result(s) found for: ivermectin.
Displaying page 1 of 2.
EudraCT Number: 2009-013276-46 | Sponsor Protocol Number: N/A | Start Date*: 2010-02-05 |
Sponsor Name:Queen Victoria Hospital | ||
Full Title: The effect of oral Ivermectin on Demodex associated blepharitis | ||
Medical condition: Demodex Follicularum associated anterior blepharitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005015-40 | Sponsor Protocol Number: IVER-303 | Start Date*: 2021-04-29 | |||||||||||
Sponsor Name:Chemo Research S.L. | |||||||||||||
Full Title: A multicentre, phase III, double-blind, randomised, parallel, placebo-controlled trial to assess efficacy and safety of early administration of Ivermectin during 3 consecutive days to prevent SARS ... | |||||||||||||
Medical condition: Coronavirus disease (COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003255-15 | Sponsor Protocol Number: Benzylbenzoat-Ivermectin-5020 | Start Date*: 2020-12-17 |
Sponsor Name:Landeskrankenhaus Salzburg | ||
Full Title: Investigation to assess the efficacy of benzyl benzoate 10/25% emulsion versus oral ivermectin for scabies treatment | ||
Medical condition: Scabies | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001994-66 | Sponsor Protocol Number: ECIT-PRO19 | Start Date*: 2020-05-06 |
Sponsor Name:Fundació Assistencial Mútua Terrassa | ||
Full Title: Ramdomised clinical trial of ivermectin for treatment and prophylaxis of COVID-19 | ||
Medical condition: SARS COVID-19 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001938-19 | Sponsor Protocol Number: mdc-TTG-CT-002 | Start Date*: 2022-03-10 | |||||||||||
Sponsor Name:MedinCell S.A. | |||||||||||||
Full Title: A multicentre randomised, Double-Blind, Placebo-controlled, Study to evaluate the efficAcy and safety of oral IVErmectin tablets in the prevention of COVID-19 (the SAIVE Trial) | |||||||||||||
Medical condition: Prophylaxis of COVID-19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001971-33 | Sponsor Protocol Number: CORIVER | Start Date*: 2020-06-02 |
Sponsor Name:Carmen Hidalgo | ||
Full Title: Pragmatic study "CORIVER": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID-19) | ||
Medical condition: SARS-COV2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002445-15 | Sponsor Protocol Number: Prevent-COVID | Start Date*: 2021-09-27 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: Placebo-kontrollierte randomisierte doppel-blinde Phase III Studie zur Wirksamkeit und Sicherheit von Ivermectin Tabletten (Driponin®) für die Prophylaxe der COVID-19 Erkrankung bei im Haushalt leb... | ||
Medical condition: COVID-19 Post-Expositionsprophylaxe | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002091-12 | Sponsor Protocol Number: HUVE-19-CT-001 | Start Date*: 2020-05-15 |
Sponsor Name:HUVEPHARMA EOOD | ||
Full Title: Multicenter, randomized, double-blind, placebo-controlled study investigating efficacy, safety and tolerability of ivermectin HUVE-19 in patients with proven SARS-CoV-2 infection (COVID-19) and man... | ||
Medical condition: confirmed SARS-CoV-2 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BG (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001474-29 | Sponsor Protocol Number: SAINT | Start Date*: 2020-05-07 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-004143-27 | Sponsor Protocol Number: STRONG-FIX | Start Date*: 2023-09-14 | |||||||||||
Sponsor Name:Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) | |||||||||||||
Full Title: Randomized non-inferiority clinical trial to evaluate the efficacy of a single fixed dose of 18 mg ivermectin for the treatment of uncomplicated strongyloidiasis | |||||||||||||
Medical condition: Strongyloidiasis is caused by a parasite that is globally distributed in tropical and sub-tropical areas. Most patients with strongyloidiasis are asymptomatic or have mild symptoms with gastrointes... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002784-24 | Sponsor Protocol Number: 2011-11 | Start Date*: 2013-09-03 |
Sponsor Name:Sacro Cuore - Don Calabria Hospital | ||
Full Title: STRONG TREAT 1 to 4 - randomized, open-label, multi centre, phase III clinical trial on multiple versus single dose of ivermectin for the treatment of strongyloidiasis | ||
Medical condition: strongyloidiasis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002723-16 | Sponsor Protocol Number: PREMIVER | Start Date*: 2018-04-20 |
Sponsor Name:Universitaetsklinikum Tuebingen | ||
Full Title: Evaluation of the potential anti-malarial effect of ivermectin: a controlled human malaria infection trial | ||
Medical condition: In spite of remarkable progress over the last 15 years, malaria continues to be a major public health problem in the developing world with an estimated 214 million cases and 438.000 deaths in 2014.... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000157-40 | Sponsor Protocol Number: RD.03.SPR.113322 | Start Date*: 2017-06-15 | |||||||||||
Sponsor Name:Galderma R&D SNC | |||||||||||||
Full Title: Efficacy comparison of Ivermectin 1% topical cream associated with Doxycycline 40 mg Modified release (MR) capsules versus Ivermectin 1% topical cream associated with Placebo in the treatment of s... | |||||||||||||
Medical condition: severe Rosacea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) CZ (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000166-15 | Sponsor Protocol Number: IVM-2021-01 | Start Date*: 2021-03-03 |
Sponsor Name:Meditop Gyógyszeripari Kft | ||
Full Title: A randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ivermectin in asymptomatic and mild severity COVID-19 patients | ||
Medical condition: COVID 19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-002283-32 | Sponsor Protocol Number: 2020-34 | Start Date*: 2020-06-12 | |||||||||||
Sponsor Name:OSPEDALE CLASSIFICATO EQUIPARATO SACRO CUORE DON CALABRIA - PRESIDIO OSPEDALIERO ACCREDITATO | |||||||||||||
Full Title: Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19 | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001999-20 | Sponsor Protocol Number: RD.03.SPR.40027 | Start Date*: 2006-10-10 | |||||||||||
Sponsor Name:Galderma Research & Development SNC | |||||||||||||
Full Title: ASSESSMENT OF THE EFFICACY AND SAFETY OF THREE CONCENTRATIONS: 1%, 0.3%, 0.1% OF CD5024 CREAM ONCE DAILY AND CD5024 1% CREAM TWICE DAILY, VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM (RO... | |||||||||||||
Medical condition: Patients with papulo-pustular rosacea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002024-21 | Sponsor Protocol Number: IVER-FNUSA-21 | Start Date*: 2021-06-09 | |||||||||||
Sponsor Name:Fakultní nemocnice u sv. Anny v Brně | |||||||||||||
Full Title: Randomized placebo controlled clinical trial evaluating the safety and efficacy of ivermectin in hospitalized patients with Covid-19 disease | |||||||||||||
Medical condition: Covid-19 disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000063-16 | Sponsor Protocol Number: RD.03.SPR.109807 | Start Date*: 2016-06-10 | |||||||||||
Sponsor Name:Galderma R&D SNC | |||||||||||||
Full Title: Efficacy and safety of CD5024 1% in acne vulgaris | |||||||||||||
Medical condition: Acne vulgaris | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005423-37 | Sponsor Protocol Number: GHRMRIPH1001 | Start Date*: 2021-02-05 |
Sponsor Name:Raincy Montfermeil intercommunal hospital group | ||
Full Title: Impact évaluation of an ivermectin single dose administration in the early phase of COVID-19 to negative viral load in SARS-CoV-2 determined by RT-PCR_ IVERCoV. | ||
Medical condition: patients with COVID 19 symptoms for less than 72 hours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018319-13 | Sponsor Protocol Number: RD.03.SPR.40106 | Start Date*: 2010-08-17 | |||||||||||
Sponsor Name:GALDERMA R&D SNC | |||||||||||||
Full Title: A DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP STUDY ASSESSING THE ACTIVITY OF CD5024 1% CREAM IN SUBJECTS WITH PAPULOPUSTULAR ROSACEA OVER 12 WEEKS TREATMENT | |||||||||||||
Medical condition: PATIENTS WITH PAPULOPUSTULAR ROSACEA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) FI (Completed) SK (Completed) HU (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
